Status:
COMPLETED
Major Depression and Messenger RNAs
Lead Sponsor:
Assistance Publique Hopitaux De Marseille
Conditions:
Major Depressive Episode
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Major Depressive Episode (MDE) affects nearly 15% of the general population. In a preliminary study, the investigators identified 12 genes whose expression was either altered between patient and contr...
Detailed Description
Rational: Major Depressive Episode (MDE) affects nearly 15% of the general population. To date, its pathophysiology remains unclear and treatment effects are often inconsistent. Therefore, it is chal...
Eligibility Criteria
Inclusion
- Arm MDE:
- Hamilton score on depression scale (HAMD-17) \> 20;
- No schizophrenia or bipolar disorder or disturbs delirious or evolutionary severe somatic pathology;
- Taken care by a psychiatric department.
- Arm control:
- No history of psychiatric pathology or evolutionary severe somatic pathology
Exclusion
- Arm MDE:
- Hamilton score on depression scale (HAMD-17) \< or = 20;
- With signs of schizophrenia or bipolar disorder or disturbs delirious;
- With evolutionary severe somatic pathology.
- Arm control:
- With signs of psychiatric pathology or evolutionary severe somatic pathology.
Key Trial Info
Start Date :
July 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00998231
Start Date
July 1 2009
Last Update
February 25 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assistance Publique-Hôpitaux de Marseille
Marseille, France